FDA Import Refusal SCS-6794514-2/10002/1 — BC LTD C/O PASTURE
The FDA refused shipment SCS-6794514-2/10002/1 from BC LTD C/O PASTURE (Singapore) on Nov 19, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 19, 2025
- Country
- Singapore
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,3280